the effects of drugs known to modify hypophyseal release of prolactin [ perphenazine , reserpine , dopa , 2-bromo-alpha-ergocryptine-mesasilate ( cb 154 ) ] were tested on sexually differentiated enzymes of hepatic ( microsomal 3 alpha- and 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase ) and renal ( cytoplasmic 17 beta-hydroxysteroid dehydrogenase ) steroid metabolism whose activities had previously been shown to be influenced by prolactin administration to hypophysectomized rats .
C0014914
17 beta-hydroxysteroid dehydrogenase
C0597520
steroid metabolism